Bryan, Garnier & Co's News

Read all the news of the independent investment banking dedicated to Growth
Share on
Filters

Merck KGaA: Waiting for more visiblity in the short term, we remain at Neutral

NEUTRAL, Fair Value EUR126 (+3%)

Published last February Monday 17, 2014

Edenred: Feed back: Long-term sustainable growth

BUY vs. NEUTRAL, Fair Value EUR26 vs. EUR25 (+20%)

Published last February Thursday 13, 2014

Prada: 2013 preliminary sales a touch below consensus

BUY, Fair Value HKD87 (+37%)

Published last February Thursday 13, 2014

BIC: Good set of Q4 numbers and improving trends are fairly valued

NEUTRAL, Fair Value EUR95 (+5%)

Published last February Thursday 13, 2014

Orpea: Solid organic growth in 2013, 2014 guidance looks robust

BUY, Fair Value Under Review

Published last February Wednesday 12, 2014

Edenred: FY 2013 results: FX impacts as anticipated. Growth target confirmed

NEUTRAL, Fair Value EUR25 (+15%)

Published last February Wednesday 12, 2014

BIC: 2013 results globally in line with a pick up in LFL growth in Q4

NEUTRAL, Fair Value EUR95 (+11%)

Published last February Wednesday 12, 2014

Software AG: Feedback from the Investors Day

BUY, Fair Value EUR34 (+24%)

Published last February Wednesday 12, 2014

Discount Eyewear Retailer National Vision to be acquired by KKR

Published last February Monday 10, 2014

Compass Group: Q1 IMS: Positive but on line with anticipation

BUY, Fair Value 1040p (+16%)

Published last February Thursday 6, 2014

The Essentials

Everything you need to know about investment banking dedicated to growth
Recent Transactions Highlights
From M&A, to IPOs see what’s been happening at Bryan, Garnier & Co this year
Join our Team
Bryan, Garnier & Co is always looking for talent in all our divisions, at all levels
Explore our opportunities